Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer

NCT01281943 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Doxil Shortage

Conditions

Liver Neoplasms

Interventions

DRUG: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2

Sponsor

Washington University School of Medicine